Skip to main content

W. Craig Hooper, PhD

Original Contribution
01/07/2010
ABSTRACT: Background. We sought to compare the efficacy of tirofiban and abciximab on platelet inhibition as well as their effects of platelet inhibition on C-reactive protein levels during percutaneous coronary intervention (PCI). Methods....
ABSTRACT: Background. We sought to compare the efficacy of tirofiban and abciximab on platelet inhibition as well as their effects of platelet inhibition on C-reactive protein levels during percutaneous coronary intervention (PCI). Methods....
ABSTRACT: Background. We sought...
01/07/2010
Journal of Invasive Cardiology